0,813  0,004  CTGF expression inhibitor
0,797  0,004  UGT1A9 substrate
0,797  0,004  UGT1A6 substrate
0,790  0,004  Aldehyde oxidase inhibitor
0,797  0,012  Caspase 9 stimulant
0,787  0,003  Genotoxic
0,747  0,003  UGT1A3 substrate
0,737  0,004  Carcinogenic, group 3
0,716  0,004  Antimutagenic
0,710  0,007  12-Lipoxygenase inhibitor
0,699  0,004  UGT1A4 substrate
0,665  0,004  Sulfotransferase substrate
0,667  0,008  NOS2 expression inhibitor
0,662  0,010  CYP1A2 substrate
0,653  0,011  Mutagenic
0,646  0,005  UGT1A1 substrate
0,666  0,025  Antineoplastic (breast cancer)
0,638  0,005  UDP-glucuronosyltransferase substrate
0,645  0,014  Carcinogenic
0,631  0,020  TNF expression inhibitor
0,621  0,016  Prostate cancer treatment
0,643  0,041  Apoptosis agonist
0,610  0,009  Lipoxygenase inhibitor
0,603  0,005  Antiseptic
0,605  0,013  Antineoplastic (cervical cancer)
0,604  0,015  Sensitization
0,588  0,015  CYP2C19 substrate
0,567  0,003  UGT2B15 substrate
0,585  0,026  15-Lipoxygenase inhibitor
0,577  0,025  Antineoplastic (colorectal cancer)
0,567  0,025  Antineoplastic (colon cancer)
0,538  0,003  SULT1A3 substrate
0,557  0,026  CYP2C9 substrate
0,544  0,015  AR expression inhibitor
0,544  0,017  Histamine release inhibitor
0,542  0,015  Ulceration
0,546  0,020  5 Hydroxytryptamine release inhibitor
0,543  0,019  Antineoplastic (melanoma)
0,536  0,013  Free radical scavenger
0,528  0,006  Topoisomerase II inhibitor
0,549  0,031  Antileukemic
0,551  0,037  Transcription factor NF kappa B inhibitor
0,531  0,017  Antioxidant
0,509  0,004  Cystathionine beta-synthase inhibitor
0,510  0,005  NOS3 expression enhancer
0,512  0,009  Peroxidase inhibitor
0,507  0,004  Pneumotoxic
0,521  0,020  Chemoprotective
0,516  0,018  NOS3 expression inhibitor
0,515  0,019  Cytostatic
0,503  0,010  UGT2B4 substrate
0,529  0,040  Antineoplastic (lung cancer)
0,508  0,019  FMO1 substrate
0,503  0,015  CYP1A2 inhibitor
0,511  0,023  GABA C receptor rho-3 antagonist
0,491  0,007  Antineoplastic (bladder cancer)
0,496  0,018  Antineoplastic (non-small cell lung cancer)
0,484  0,006  Amylase inhibitor
0,513  0,038  CYP3A4 substrate
0,489  0,020  Antineoplastic (glioma)
0,489  0,022  Caspase 3 stimulant
0,486  0,024  Cardioprotectant
0,494  0,035  Antipruritic, allergic
0,476  0,017  Antineoplastic (glioblastoma multiforme)
0,473  0,016  Superoxide dismutase inhibitor
0,455  0,004  Neurotrophic factor enhancer
0,453  0,005  5-Lipoxygenase inhibitor
0,478  0,030  Antineoplastic (ovarian cancer)
0,453  0,005  Carcinogenic, group 2B
0,466  0,022  Cardiovascular analeptic
0,461  0,018  Amyloid beta aggregation inhibitor
0,472  0,035  Teratogen
0,446  0,010  Skin whitener
0,467  0,031  CYP2D6 substrate
0,456  0,023  Chemopreventive
0,432  0,003  Keratolytic
0,438  0,015  RNA-directed DNA polymerase inhibitor
0,453  0,033  Antihypercholesterolemic
0,449  0,031  Cytotoxic
0,430  0,017  Antineoplastic enhancer
0,421  0,009  UGT2B7 substrate
0,434  0,023  Hypoxia-inducible factor 1 alpha inhibitor
0,438  0,030  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,431  0,023  Antipyretic
0,403  0,003  SULT1A1 substrate
0,407  0,011  Melanin inhibitor
0,432  0,038  Embryotoxic
0,449  0,057  Antibacterial
0,404  0,016  Flavin-containing monooxygenase substrate
0,413  0,026  DNA damaging
0,390  0,004  Estrogen receptor alpha antagonist
0,390  0,004  Estrogen receptor beta antagonist
0,417  0,035  Antineoplastic (brain cancer)
0,423  0,043  Bone diseases treatment
0,397  0,020  Antineoplastic (small cell lung cancer)
0,400  0,026  Cardiodepressant
0,394  0,020  FMO3 substrate
0,378  0,004  Carbonic anhydrase III inhibitor
0,378  0,005  Estrogen antagonist
0,387  0,016  Dual specificity phosphatase inhibitor
0,387  0,017  Antineoplastic (sarcoma)
0,403  0,037  Antineoplastic (pancreatic cancer)
0,368  0,005  Topoisomerase II alpha inhibitor
0,417  0,054  CYP2C19 inhibitor
0,364  0,003  NAD(P)H dehydrogenase (quinone) inhibitor
0,388  0,031  Proliferative diseases treatment
0,379  0,024  Antihypertriglyceridemic
0,362  0,010  MAO A inhibitor
0,353  0,003  Creatine kinase inhibitor
0,365  0,016  Antihypotensive
0,359  0,012  Lipid peroxidase inhibitor
0,401  0,057  CYP2C9 inhibitor
0,350  0,008  Heat shock protein 90 alpha antagonist
0,356  0,015  Tyrosine 3 hydroxylase inhibitor
0,382  0,041  Antiosteoporotic
0,369  0,029  Antineoplastic (osteosarcoma)
0,343  0,007  UGT2B1 substrate
0,344  0,008  Aldehyde dehydrogenase inhibitor
0,363  0,028  DNA synthesis inhibitor
0,346  0,013  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,338  0,006  Heat shock protein 90 antagonist
0,358  0,031  Pyruvate kinase inhibitor
0,369  0,051  Respiratory analeptic
0,344  0,026  Abortion inducer
0,351  0,034  Antineoplastic (liver cancer)
0,320  0,005  Carbonic anhydrase VI inhibitor
0,322  0,009  Topoisomerase I inhibitor
0,347  0,035  Transcription factor STAT inhibitor
0,317  0,009  Hexokinase inhibitor
0,393  0,086  Calcium channel L-type activator
0,355  0,051  Radioprotector
0,379  0,075  GST A substrate
0,322  0,018  MAO inhibitor
0,344  0,041  Radiosensitizer
0,309  0,009  Antifungal enhancer
0,410  0,110  Alpha-glucosidase inhibitor
0,337  0,040  Antineoplastic (renal cancer)
0,331  0,035  Interleukin agonist
0,330  0,035  Nitric oxide antagonist
0,333  0,039  Transcription factor STAT3 inhibitor
0,309  0,017  Monophenol monooxygenase inhibitor
0,293  0,003  DOPA decarboxylase inhibitor
0,352  0,061  ICAM1 expression inhibitor
0,295  0,005  Estrogen agonist
0,304  0,019  Interferon gamma antagonist
0,293  0,011  UGT2B9 substrate
0,298  0,017  Protein kinase stimulant
0,338  0,058  Calcium channel activator
0,285  0,007  Histidine decarboxylase inhibitor
0,320  0,045  Antineoplastic (lymphoma)
0,319  0,047  Hypoglycemic
0,309  0,038  Cyclic AMP phosphodiesterase inhibitor
0,277  0,007  VEGF expression inhibitor
0,299  0,029  Eye irritation, high
0,292  0,028  VCAM1 expression inhibitor
0,316  0,052  Antihypoxic
0,296  0,032  5 Hydroxytryptamine 1E antagonist
0,273  0,010  Antihemorrhagic
0,303  0,042  Antiparasitic
0,277  0,016  NADPH oxidase inhibitor
0,279  0,018  Nitric-oxide synthase stimulant
0,304  0,043  5 Hydroxytryptamine uptake stimulant
0,321  0,064  5 Hydroxytryptamine release stimulant
0,320  0,064  Analeptic
0,260  0,005  CF transmembrane conductance regulator agonist
0,271  0,017  Glutathione S-transferase substrate
0,276  0,022  Tubulin antagonist
0,317  0,064  Spasmolytic
0,259  0,006  Coagulant
0,259  0,011  UGT2B10 substrate
0,253  0,007  Antirickettsial
0,296  0,051  GST M1-1 substrate
0,248  0,005  TRPA1 agonist
0,296  0,053  Antiamyloidogenic
0,251  0,012  Xanthine oxidase inhibitor
0,314  0,076  Vasodilator, coronary
0,277  0,039  Anesthetic general
0,314  0,076  Apoptosis antagonist
0,250  0,012  Carbonic anhydrase XV inhibitor
0,385  0,148  Antiinflammatory
0,308  0,072  Sodium/bile acid cotransporter inhibitor
0,251  0,016  Alkylator
0,263  0,030  Antipruritic, non-allergic
0,237  0,007  Antihelmintic (Trematoda)
0,306  0,078  Antifungal
0,235  0,007  Photosensitizer
0,267  0,040  Antihelmintic
0,228  0,002  ATP citrate lysase inhibitor
0,225  0,005  SULT1E1 substrate
0,225  0,004  Estrogen receptor beta agonist
0,232  0,013  Toll-Like receptor 2 antagonist
0,290  0,072  Antineoplastic (multiple myeloma)
0,233  0,016  Antineoplastic antibiotic
0,235  0,018  DNA intercalator
0,297  0,081  Antineoplastic (endocrine cancer)
0,225  0,009  NAT2 substrate
0,219  0,007  Postmenopausal disorders treatment
0,219  0,006  Beta tubulin antagonist
0,214  0,004  Estrogen receptor alpha agonist
0,219  0,009  MAP3K9 inhibitor
0,252  0,043  Hepatoprotectant
0,228  0,023  Antiprotozoal (Coccidial)
0,210  0,004  Estradiol 17 beta-dehydrogenase inhibitor
0,239  0,034  Protein-tyrosine phosphatase inhibitor
0,211  0,009  HIV-1 integrase (3'-Processing) inhibitor
0,211  0,009  HIV-1 integrase (Overall Integration) inhibitor
0,219  0,018  Arachidonic acid antagonist
0,210  0,009  Antineoplastic (uterine cancer)
0,249  0,049  Sigma receptor agonist
0,233  0,034  Contraceptive
0,235  0,037  Antihelmintic (Nematodes)
0,298  0,100  Antiprotozoal (Plasmodium)
0,291  0,094  Antithrombotic
0,239  0,044  Dual specificity phosphatase 3 inhibitor
0,257  0,063  Antineoplastic (lymphocytic leukemia)
0,243  0,050  Antialcoholic
0,223  0,031  Antidote
0,207  0,016  Cyclooxygenase 3 inhibitor
0,264  0,073  Aryl hydrocarbon receptor agonist
0,208  0,020  Interleukin 4 antagonist
0,220  0,032  Skin irritative effect
0,243  0,056  Peptidyltransferase inhibitor
0,292  0,106  Prostaglandin dehydrogenase inhibitor
0,199  0,014  Antispirochetal
0,222  0,037  LDLR expression enhancer
0,251  0,068  Vasodilator
0,219  0,037  Antineoplastic (squamous cell carcinoma)
0,211  0,029  ATPase inhibitor
0,253  0,071  Antiprotozoal (Leishmania)
0,186  0,005  Ca2+-transporting ATPase inhibitor
0,185  0,004  Topoisomerase II beta inhibitor
0,204  0,024  Chelator
0,185  0,006  UGT2B11 substrate
0,195  0,016  Adenylate cyclase stimulant
0,301  0,123  Antiprotozoal
0,227  0,050  Insulin sensitizer
0,281  0,104  Cholesterol antagonist
0,226  0,050  P-glycoprotein inhibitor
0,180  0,004  Heat shock protein 90 beta antagonist
0,228  0,053  Non-steroidal antiinflammatory agent
0,306  0,130  MAP kinase kinase 6 inhibitor
0,179  0,004  SULT1A2 substrate
0,331  0,156  Antineoplastic (solid tumors)
0,178  0,004  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,201  0,028  GABA C receptor rho-2 antagonist
0,205  0,032  M18 aspartyl aminopeptidase inhibitor
0,280  0,108  Vasodilator, peripheral
0,179  0,007  Anabolic
0,194  0,024  Farnesoid X receptor antagonist
0,202  0,032  Acetylcholinesterase inhibitor
0,180  0,011  HIV-1 integrase (Strand Transfer) inhibitor
0,202  0,033  Cyclooxygenase 1 inhibitor
0,210  0,041  Succinate dehydrogenase inhibitor
0,203  0,034  Antidiarrheal
0,176  0,007  Alpha tubulin antagonist
0,184  0,017  Gastritis treatment
0,195  0,030  Psychosexual dysfunction treatment
0,197  0,032  Mannose-6-phosphate isomerase inhibitor
0,193  0,028  Cholesterol synthesis inhibitor
0,180  0,015  Arylamine N-Acetyltransferase substrate
0,193  0,029  Antihyperlipoproteinemic
0,246  0,084  Gastrin inhibitor
0,171  0,011  Aromatase inhibitor
0,195  0,035  Alkaline phosphatase inhibitor
0,186  0,027  MAO B inhibitor
0,196  0,040  Phobic disorders treatment
0,200  0,044  Phospholipase C inhibitor
0,171  0,016  Alcohol dehydrogenase inhibitor
0,207  0,052  Mcl-1 antagonist
0,169  0,015  Xanthine oxidase substrate
0,171  0,018  Antiviral (Influenza B)
0,201  0,048  Acaricide
0,168  0,015  Actinic keratosis treatment
0,169  0,018  Beta glucuronidase inhibitor
0,167  0,016  Prolactin inhibitor
0,168  0,019  Heat shock protein 70 antagonist
0,158  0,010  NAT1 substrate
0,209  0,061  CYP2B6 inhibitor
0,202  0,055  Lipocortins synthesis antagonist
0,150  0,003  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,305  0,159  DNA directed DNA polymerase inhibitor
0,173  0,027  Endometrios treatment
0,164  0,021  DNA repair enzyme inhibitor
0,158  0,017  Electron transport complex I inhibitor
0,159  0,019  Urease inhibitor
0,245  0,106  Streptokinase A inhibitor
0,150  0,013  CDC25A inhibitor
0,241  0,105  Insulysin inhibitor
0,144  0,008  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,159  0,023  AMP-activated protein kinase stimulant
0,151  0,015  Macrophage migration inhibitory factor inhibitor
0,159  0,027  Contraceptive female
0,234  0,103  Immunostimulant
0,152  0,021  Transcription factor STAT6 inhibitor
0,174  0,043  Alpha-N-acetylglucosaminidase inhibitor
0,153  0,023  Breast cancer-resistant protein inhibitor
0,138  0,008  CDC25B inhibitor
0,181  0,052  Antineoplastic (carcinoma)
0,152  0,024  NMDA receptor antagonist
0,157  0,030  Choleretic
0,188  0,062  Antineoplastic (gastric cancer)
0,179  0,053  Catenin beta inhibitor
0,137  0,011  TRPA1 antagonist
0,162  0,037  Adenylate cyclase inhibitor
0,153  0,028  Antineoplastic, alkylator
0,153  0,028  GABA C receptor antagonist
0,201  0,078  DNA methylase inhibitor
0,262  0,139  Immunosuppressant
0,140  0,018  Antiviral (Trachoma)
0,155  0,035  Microtubule formation inhibitor
0,143  0,023  Carbonic anhydrase XIII inhibitor
0,146  0,027  Multidrug resistance-associated protein 1 inhibitor
0,151  0,033  Papain-like protease (SARS coronavirus) inhibitor
0,140  0,022  Telomerase inhibitor
0,137  0,022  Thioredoxin inhibitor
0,132  0,017  Glutamate decarboxylase inhibitor
0,243  0,128  Angiogenesis inhibitor
0,128  0,014  Thioredoxin reductase inhibitor
0,162  0,048  Toll-Like receptor antagonist
0,177  0,065  Antineoplastic (bone cancer)
0,187  0,076  DNA methyltransferase I inhibitor
0,143  0,032  Mediator release inhibitor
0,155  0,044  Protein-tyrosine phosphatase 1B inhibitor
0,118  0,007  Fatty acid synthase inhibitor
0,149  0,039  Vanilloid 1 agonist
0,252  0,141  Stroke treatment
0,150  0,041  Growth stimulant
0,151  0,043  Antiprotozoal (Amoeba)
0,145  0,037  Expectorant
0,208  0,102  Myocardial infarction treatment
0,138  0,032  Antifungal (Pneumocystis)
0,117  0,011  Estrogen-related receptor beta agonist
0,134  0,030  GABA C receptor rho-1 antagonist
0,280  0,176  DNA polymerase beta inhibitor
0,155  0,052  MAP kinase kinase 4 inhibitor
0,168  0,065  Neurotensin receptor agonist
0,144  0,042  Gout treatment
0,107  0,004  Dopamine D5 agonist
0,118  0,016  HIV-1 integrase inhibitor
0,151  0,049  DNA polymerase I inhibitor
0,198  0,096  Angiogenesis stimulant
0,118  0,017  GABA aminotransferase inhibitor
0,206  0,104  Antiviral (West Nile virus)
0,167  0,066  Uterine stimulant
0,155  0,055  Bone formation stimulant
0,211  0,110  Antiprotozoal (Trypanosoma)
0,107  0,008  MAP kinase kinase 7 inhibitor
0,187  0,088  Psychostimulant
0,133  0,034  Chronic obstructive bronchitis treatment
0,128  0,030  Androgen antagonist
0,138  0,039  GABA C receptor agonist
0,104  0,007  SULT2A1 substrate
0,124  0,028  Paget's disease treatment
0,137  0,041  Mucolytic
0,102  0,006  Transcription factor RelA inhibitor
0,144  0,051  Antibacterial (Helicobacter pylori)
0,111  0,017  Narcotic antagonist
0,121  0,028  Porphobilinogen synthase inhibitor
0,135  0,044  Excitatory amino acid transporter EAAC1 inhibitor
0,184  0,094  Histone acetyltransferase inhibitor
0,162  0,073  Prostate disorders treatment
0,110  0,021  Leukotriene synthesis inhibitor
0,106  0,017  Alcohol oxidase inhibitor
0,101  0,012  Antimycoplasmal
0,127  0,039  UDP-glucose 4-epimerase inhibitor
0,108  0,022  D-Ala-D-Ala ligase inhibitor
0,089  0,005  Adenylate cyclase 1 inhibitor
0,092  0,008  Postcoital contraceptive
0,128  0,044  Antischistosomal
0,196  0,113  Acute neurologic disorders treatment
0,111  0,029  Bile acid receptor antagonist
0,116  0,035  Protein kinase C zeta inhibitor
0,178  0,097  Antimitotic
0,098  0,016  Xanthine dehydrogenase inhibitor
0,135  0,055  Antitussive
0,162  0,082  Muscle relaxant
0,154  0,075  Diuretic
0,154  0,076  Carcinogenic, group 1
0,084  0,006  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,148  0,072  Cyclooxygenase inhibitor
0,151  0,075  Aldose reductase substrate
0,112  0,037  Triose-phosphate isomerase inhibitor
0,117  0,043  Potassium channel (Ca-activated) activator
0,103  0,029  Glutamate dehydrogenase inhibitor
0,109  0,035  Antidote, mercury
0,165  0,092  Platelet adhesion inhibitor
0,103  0,030  Glycine receptor antagonist
0,093  0,019  Aldose reductase inhibitor
0,148  0,075  Movement disorders treatment
0,149  0,077  Cholinergic
0,080  0,007  Retinoid X alpha receptor agonist
0,090  0,019  Androgen agonist
0,097  0,026  Dopamine D1 antagonist
0,188  0,119  Tumour necrosis factor alpha release inhibitor
0,128  0,059  Sphingosine 1-phosphate receptor 4 antagonist
0,103  0,035  Inducible nitric-oxide synthase inhibitor
0,209  0,142  Antimycobacterial
0,141  0,074  Skeletal muscle relaxant
0,140  0,074  Pregnane X receptor agonist
0,134  0,068  Antiprotozoal (Trichomonas)
0,143  0,077  Hemostatic
0,105  0,039  NADH dehydrogenase inhibitor
0,165  0,100  Antiviral (Influenza)
0,113  0,049  GST T1-1 substrate
0,139  0,077  Antifungal (Cryptococcus)
0,138  0,077  Cell wall synthesis inhibitor
0,096  0,035  Na+ K+ transporting ATPase inhibitor
0,070  0,010  Retinoid X receptor agonist
0,166  0,106  Interleukin antagonist
0,096  0,036  Antibiotic
0,077  0,017  Heme oxygenase stimulant
0,106  0,047  Uric acid excretion stimulant
0,104  0,045  ABCA1 expression enhancer
0,101  0,043  Ornithine decarboxylase inhibitor
0,112  0,055  Antiprotozoal (Toxoplasma)
0,099  0,042  ATPase (Vacuolar H+) inhibitor
0,091  0,035  CC chemokine 5 receptor agonist
0,130  0,074  Sphingosine 1-phosphate receptor 2 antagonist
0,153  0,097  Tumour necrosis factor antagonist
0,129  0,074  Anesthetic
0,064  0,009  DNA gyrase subunit A inhibitor
0,076  0,021  Cannabinoid CB2 receptor antagonist
0,155  0,101  Toxic, respiratory center
0,083  0,029  Anticholelithogenic
0,097  0,044  Tocolytic
0,137  0,084  Sphingosine 1-phosphate receptor 5 antagonist
0,070  0,017  DNA helicase inhibitor
0,075  0,023  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,056  0,004  Estrogen-related receptor beta antagonist
0,062  0,010  Guanylate cyclase inhibitor
0,086  0,035  Cyclin B3 inhibitor
0,180  0,130  Vascular (periferal) disease treatment
0,099  0,049  Antithrombocytopenic
0,284  0,235  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,066  0,016  Dopamine D5 antagonist
0,110  0,061  Antihelmintic (Fasciola)
0,106  0,058  Antifungal (Aspergillus)
0,095  0,047  Interleukin 5 antagonist
0,124  0,076  Cyclooxygenase 2 inhibitor
0,135  0,088  Antiviral (Influenza A)
0,092  0,047  Granulocyte macrophage colony stimulating factor agonist
0,136  0,091  Antiviral (Herpes)
0,082  0,036  Glycine receptor agonist
0,099  0,054  Phosphodiesterase 6D inhibitor
0,074  0,030  Antihemophilic
0,052  0,008  Protein 30S ribosomal subunit inhibitor
0,106  0,063  HDL-cholesterol increasing
0,102  0,060  Butyrylcholinesterase inhibitor
0,120  0,078  Antiviral (Papilloma)
0,073  0,031  NMDA 2C receptor antagonist
0,127  0,085  Neurotrophic factor
0,074  0,032  5 Hydroxytryptamine 2A agonist
0,098  0,057  Interleukin 12 antagonist
0,121  0,079  Retinoprotector
0,176  0,134  Antidiabetic symptomatic
0,074  0,033  Protease 3C (Human rhinovirus) inhibitor
0,074  0,033  Uterine relaxant
0,064  0,023  Dihydroorotate oxidase inhibitor
0,123  0,083  Toll-Like receptor 9 antagonist
0,134  0,094  Phospholipase A2 inhibitor
0,071  0,032  Antidote, heavy metal
0,068  0,029  Carbonic anhydrase VB inhibitor
0,096  0,057  GST P1-1 substrate
0,079  0,041  Purinergic P2X2 antagonist
0,119  0,082  Antiacne
0,062  0,026  Pregnane X receptor antagonist
0,076  0,040  Carbonic anhydrase VA inhibitor
0,057  0,021  Carbonic anhydrase VII inhibitor
0,075  0,041  Dopamine agonist
0,045  0,011  Catechol O-methyltransferase inhibitor
0,049  0,016  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,109  0,076  Proteasome inhibitor
0,051  0,018  Progesterone antagonist
0,078  0,045  Cathepsin G inhibitor
0,112  0,080  Alcohol dehydrogenase substrate
0,109  0,078  Interleukin 8 antagonist
0,118  0,089  Cocaine dependence treatment
0,166  0,136  Antiviral (Ebola)
0,055  0,026  Squalene epoxidase inhibitor
0,049  0,020  NMDA receptor subunit 3A antagonist
0,200  0,172  CYP3A4 inhibitor
0,034  0,006  Vanilloid 2 agonist
0,070  0,043  Carbonic anhydrase V inhibitor
0,082  0,055  Opioid kappa receptor antagonist
0,194  0,167  Thyroid hormone antagonist
0,079  0,053  Antidote, organophosphates
0,044  0,018  Retinoid X receptor antagonist
0,041  0,015  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,084  0,059  Carcinogenic, group 2A
0,050  0,025  NMDA receptor subunit 3B antagonist
0,140  0,115  Sedative
0,027  0,003  Antibiotic Tetracycline-like
0,144  0,121  Death-associated protein kinase 2 inhibitor
0,032  0,008  Dopamine D1 agonist
0,102  0,079  Interleukin 1b antagonist
0,027  0,004  Antibiotic Anthracycline-like
0,096  0,075  Ferrochelatase inhibitor
0,067  0,045  Glutamate (mGluR6) antagonist
0,043  0,022  5-Alpha-reductase inhibitor
0,088  0,067  Antiviral (Hepatitis A)
0,075  0,054  GABA B receptor agonist
0,056  0,036  Adenine nucleotide translocase inhibitor
0,067  0,047  Glutamate (mGluR7) antagonist
0,051  0,031  Carbonic anhydrase XIV inhibitor
0,145  0,125  I kappa B kinase epsilon inhibitor
0,084  0,064  Opioid antagonist
0,030  0,011  Sodium/glucose cotransporter 1 inhibitor
0,070  0,051  NMDA 2 receptor antagonist
0,068  0,049  Phosphofructokinase-1 inhibitor
0,134  0,116  Antipruritic
0,056  0,038  5 Hydroxytryptamine 7 agonist
0,083  0,065  Antileprosy
0,061  0,042  Purinergic P2X1 antagonist
0,051  0,033  CD45 antagonist
0,030  0,013  Sodium/glucose cotransporter 2 inhibitor
0,072  0,056  Phosphodiesterase VI inhibitor
0,202  0,186  Interleukin 2 agonist
0,029  0,013  Sodium/glucose cotransporter inhibitor
0,047  0,030  Purinergic P2X4 antagonist
0,029  0,014  Thyroid hormone agonist
0,040  0,025  Retinoic acid alpha receptor agonist
0,094  0,080  Toll-Like receptor 4 antagonist
0,053  0,039  Leukotriene B4 antagonist
0,058  0,045  Cyclin D1 inhibitor
0,149  0,136  Antiulcerative
0,041  0,029  Liver X receptor alpha agonist
0,050  0,038  NMDA 2A receptor antagonist
0,062  0,050  Calcium channel P-type blocker
0,081  0,069  Vanilloid agonist
0,047  0,035  Glucose-6-phosphate isomerase inhibitor
0,089  0,079  Nitric-oxide synthase inhibitor
0,088  0,077  Dementia treatment
0,068  0,058  Peroxisome proliferator-activated receptor gamma antagonist
0,046  0,036  Aldosterone antagonist
0,212  0,203  Antineoplastic (non-Hodgkin's lymphoma)
0,084  0,075  Platelet activating factor beta antagonist
0,039  0,031  Phenylethanolamine N methyltransferase inhibitor
0,040  0,032  Cholesterol absorption inhibitor
0,181  0,173  Thyroid hormone beta antagonist
0,093  0,085  5 Hydroxytryptamine 3A agonist
0,062  0,055  Phenylalanine 4-hydroxylase inhibitor
0,061  0,054  Beta adrenoreceptor antagonist
0,112  0,104  Hair growth stimulant
0,062  0,055  Check point kinase 1 inhibitor
0,073  0,065  Interferon agonist
0,028  0,021  Estrogen-related receptor gamma antagonist
0,084  0,077  Vascular dementia treatment
0,031  0,025  Glutamate (mGluR3) agonist
0,034  0,028  Arginase inhibitor
0,021  0,015  Estrone sulfatase inhibitor
0,020  0,015  Retinoid X beta receptor antagonist
0,024  0,019  Glutamate (mGluR1) agonist
0,056  0,051  Ryanodine receptor antagonist
0,036  0,031  Glucose-6-phosphate dehydrogenase inhibitor
0,057  0,052  Bcl-xL inhibitor
0,032  0,028  Retinoid X alpha receptor antagonist
0,044  0,040  Cholesterol esterase inhibitor
0,180  0,177  Hepatic disorders treatment
0,060  0,057  Beta 3 adrenoreceptor antagonist
0,031  0,029  Protein kinase (CK2) beta inhibitor
0,152  0,150  Antiviral (HIV)
0,039  0,037  GABA B receptor antagonist
0,033  0,031  Adenosine uptake inhibitor
0,021  0,019  CYP24 inhibitor
0,142  0,140  Platelet aggregation inhibitor
0,047  0,045  Anesthetic inhalation
0,066  0,064  CYP2A6 inhibitor
0,109  0,107  Antiparkinsonian, tremor relieving
0,030  0,029  Sodium-dependent vitamin C transporter 2 inhibitor
0,054  0,053  Lipocortins synthesis agonist
0,058  0,057  Opioid mu receptor antagonist
0,053  0,052  Opioid delta receptor antagonist
0,029  0,028  Estrogen-related receptor alpha antagonist
0,111  0,110  Nav1.6 sodium channel blocker
0,020  0,019  Glutamate (mGluR1a) agonist
0,063  0,063  Aminopeptidase I inhibitor

